Akesobio IPO Initiation: The Tough Get Going
Akeso Biopharma Inc (1495016D CH)Ā is a clinical-stage biopharmaceutical company with aims to address global unmet medical needs in oncology,...
559 Views
Akesobio (åŗ·ę¹ēē©) Pre-IPO: Clinical Trial Updates from PHIP
Akesobio is a clinical-stage biopharmaceutical company with a focus on developing biologics drugs for oncology and autoimmune. The company plans to...
595 Views
Akesobio (åŗ·ę¹ēē©) Pre-IPO: Thoughts on Valuation
Akesobio is a clinical-stage biopharmaceutical company with a focus on developing biologics drugs for oncology and autoimmune. The company plans to...
711 Views
ECM Weekly (9 Feb 2020) - Mr. DIY, Kingsoft Cloud, SBI Cards, CAMS, Equitas SFB, Akeso Bio
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Even...
506 Views
Akesobio (åŗ·ę¹ēē©) Pre-IPO: Late in the PD-1 Game but Products Are Promising
Akesobio is a clinical-stage biopharmaceutical company with a focus on developing biologics drugs for oncology and autoimmune. The company plans to...
709 Views